Medtronic PLC
I · KI-Analyse
Kurzfassung
Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.
Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].
Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.
Sentinellis-Score
5.3/10
Moderate concerns
Marktkapitalisierung
$100.9B
Umsatz (12 Monate)
$33.5B
II · Aktuelle Nachrichten
Was den Kurs bewegt hat
6 stories · ranked by relevance
- macro2026-05-18
Mental Health Matters at Medtronic. Explore Our Employee Benefits
Yahoo Finance
- macro2026-05-19
Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks
Simply Wall St
- macro2026-05-18
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
Yahoo Finance
- macro2026-05-18
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
Yahoo Finance
- macro2026-05-17
A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years
Yahoo Finance
- macro2026-05-14
Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?
Yahoo Finance
Premium · kostenlos mit jedem Konto
Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]
Risiken
5
Chancen
6
Warnsignale
3
Führung
10
23 weitere Erkenntnisse im vollständigen Bericht — kostenlos mit jedem Konto.
Vollständige Medtronic PLC-Analyse freischalten
Erstellen Sie ein kostenloses Konto für den vollständigen KI-Bericht mit Quellenangaben im Text.
- 5 Risiken, 6 Chancen und 3 Warnsignale — jeweils mit Quelle
- Über 100 Finanzkennzahlen mit Charts und Vergleichen
- Vollständige Nachrichten-Zusammenfassungen mit Quellenlinks
- Führungsteam und Vergütung
- PDF-Export für offline
III · Ähnliche Unternehmen
Das könnte Sie auch interessieren
Same sector · Healthcare or comparable health
Auf Ihre Watchlist setzen?